Principal And Senior Equity Research Analyst
CurrentCreating proprietary qualitative and quantitative research equity reports centered around biotech catalysts and binary events.Developing comprehensive financial portfolios for clients centered around their goals and risk tolerances.Utilizing my own proprietary research to obtain market beating returns of 25-30% per year on average.Supervising and managing.